glp 1 derived from GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity | Saudi Pharmaceutical Journal GLP-1-based therapies for type 2

A Review of FDA-Approved Medications for Chronic Weight Management

Tirzepatide: SURMOUNT-1 (72 Weeks) The SURMOUNT-1 trial enrolled 2,539 adults with obesity (BMI 30) or overweight with comorbidities

Niacinamide improves uneven skin tone 5

What is the growth forecast for the United States in the GLP-1 Receptor Agonists market

Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse

Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis